Kalyanam Nagabhushanam Selected Research

pterostilbene

4/2022	Pterostilbene and Its Derivative 3'-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway.
1/2022	The Anti-Obesity and Anti-Inflammatory Capabilities of Pterostilbene and its Colonic Metabolite Pinostilbene Protect against Tight Junction Disruption from Western Diet Feeding.
11/2021	Dietary Pterostilbene and Resveratrol Modulate the Gut Microbiota Influenced by Circadian Rhythm Dysregulation.
6/2021	Pterostilbene Attenuates High-Fat Diet and Dextran Sulfate Sodium-Induced Colitis via Suppressing Inflammation and Intestinal Fibrosis in Mice.
1/2021	3'-Hydroxypterostilbene Inhibits 7,12-Dimethylbenz[a]anthracene (DMBA)/12-O-Tetradecanoylphorbol-13-Acetate (TPA)-Induced Mouse Skin Carcinogenesis.
9/2019	Pterostilbene Inhibits Adipocyte Conditioned-Medium-Induced Colorectal Cancer Cell Migration through Targeting FABP5-Related Signaling Pathway.
2/2017	Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat.
3/2011	Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway.
9/2007	Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kalyanam Nagabhushanam Research Topics

Disease

11	Inflammation (Inflammations) 04/2022 - 03/2011
10	Neoplasms (Cancer) 01/2022 - 09/2007
7	Obesity 01/2022 - 12/2019
7	Carcinogenesis 01/2021 - 03/2011
4	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2021
4	Colitis 06/2021 - 11/2017
3	COVID-19 04/2022 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2019
3	Fibrosis (Cirrhosis) 11/2021 - 01/2020
2	Non-alcoholic Fatty Liver Disease 04/2022 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2021 - 11/2021
2	Body Weight (Weight, Body) 01/2021 - 01/2015
2	Colitis-Associated Neoplasms 01/2021 - 11/2017
1	Infections 04/2022
1	Insulin Resistance 04/2022
1	Cardiotoxicity 01/2022
1	Weight Gain 01/2022
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2022
1	Overweight 01/2022
1	Jet Lag Syndrome 11/2021
1	Weight Loss (Weight Reduction) 02/2021
1	Hyperplasia 01/2021
1	Experimental Arthritis 01/2021
1	Hyperlipidemias (Hyperlipidemia) 12/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020

Drug/Important Bio-Agent (IBA)

9	pterostilbeneIBA 04/2022 - 09/2007
6	StilbenesIBA 01/2022 - 03/2011
5	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2017
5	ResveratrolIBA 11/2021 - 03/2011
4	3'-hydroxypterostilbeneIBA 04/2022 - 11/2017
4	3,3',4,5'-tetrahydroxystilbeneIBA 01/2022 - 11/2021
4	AzoxymethaneIBA 01/2021 - 03/2011
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
3	CurcuminIBA 08/2021 - 11/2011
3	garcinolIBA 01/2021 - 12/2010
3	Dextrans (Dextran)FDA Link 01/2021 - 11/2017
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021 - 11/2017
2	LipidsIBA 04/2022 - 04/2021
2	Sirtuin 1IBA 04/2022 - 01/2022
2	SeleniumIBA 04/2022 - 01/2021
2	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2021 - 11/2021
2	puag-haadIBA 10/2021 - 12/2019
2	anthraceneIBA 01/2021 - 08/2012
2	Triglycerides (Triacylglycerol)IBA 12/2020 - 12/2019
2	AntioxidantsIBA 01/2020 - 03/2011
2	tetrahydrocurcuminIBA 12/2011 - 11/2011
2	Dronabinol (THC)FDA LinkGeneric 12/2011 - 11/2011
1	Insulin (Novolin)FDA Link 04/2022
1	VaccinesIBA 04/2022
1	Antiviral Agents (Antivirals)IBA 04/2022
1	Nonesterified Fatty Acids (NEFA)IBA 04/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	InterleukinsIBA 01/2022
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 01/2022
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2022
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022
1	scirpusin AIBA 01/2022
1	scirpusin BIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	pinostilbeneIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	EnzymesIBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 10/2021
1	feruloylacetoneIBA 08/2021
1	Dextran SulfateIBA 06/2021
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2021
1	astaxanthine (astaxanthin)IBA 04/2021
1	Dietary Fiber FDA Link 04/2021
1	Polysaccharides (Glycans)IBA 04/2021
1	SulfurIBA 04/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	CarcinogensIBA 01/2021
1	AcidsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021
1	Celecoxib (Celebrex)FDA Link 01/2021
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Cyclin B1IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	PhytochemicalsIBA 01/2021
1	MineralsIBA 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2021
1	3'-hydroxydaidzeinIBA 12/2020
1	CholesterolIBA 12/2020
1	GlucosidasesIBA 01/2020
1	Amylases FDA Link 01/2020

Therapy/Procedure

4	Therapeutics 04/2022 - 01/2021
1	Oral Administration 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Diet Therapy (Therapy, Diet) 02/2021